Literature DB >> 12643873

Late onset Ommaya reservoir infection due to Staphylococcus aureus: case report and review of Ommaya Infections.

B Mechleb1, F Khater, A Eid, G David, J P Moorman.   

Abstract

The Ommaya reservoir system has been used for the treatment of chronic central nervous system infections and intracranial tumors for more than three decades. The majority of reported Ommaya reservoir infections occur proximate to the time the device is accessed. A review of the literature reveals that late onset of reservoir infection is quite rare. We report a case of Ommaya reservoir infection due to Staphylococcus aureus that was diagnosed seven years after its insertion and usage for intracerebral non-Hodgkin's lymphoma and review the literature on the microbiology and management of Ommaya reservoir infections.

Entities:  

Mesh:

Year:  2003        PMID: 12643873     DOI: 10.1053/jinf.2002.1111

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Infections in neuro-oncology.

Authors:  P Gaviani; A Silvani; E Lamperti; A Botturi; G Simonetti; I Milanesi; D Ferrari; A Salmaggi
Journal:  Neurol Sci       Date:  2011-11       Impact factor: 3.307

2.  Placement of Ommaya reservoir following endoscopic third ventriculostomy in pediatric hydrocephalic patients: a critical reappraisal.

Authors:  Bo Xiao; Jonathan Roth; Suhas Udayakumaran; Liana Beni-Adani; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2010-12-23       Impact factor: 1.475

3.  Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472 intraventricular drug administrations in 98 patients.

Authors:  Andreas Peyrl; Monika Chocholous; Amedeo A Azizi; Thomas Czech; Christian Dorfer; Dieter Mitteregger; Johannes Gojo; Elke Minichmayr; Irene Slavc
Journal:  J Neurooncol       Date:  2014-07-14       Impact factor: 4.130

4.  Management of skin erosion following deep brain stimulation.

Authors:  Michele Lanotte; Giovanni Verna; Pier Paolo Panciani; Antonio Taveggia; Maurizio Zibetti; Leonardo Lopiano; Alessandro Ducati
Journal:  Neurosurg Rev       Date:  2008-09-05       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.